紧急召集!肿瘤学高性价比 SCI 期刊征稿开启,错

作者:集群智慧期刊云 发布时间:2025-11-18

  Frontiers in Oncology(ISSN:2234-943X)是瑞士Frontiers出版社旗下的开源SCI期刊,中科院医学大类3区,肿瘤学小类学科4区,JCR肿瘤学Q2分区,最新影响因子3.5,自引率5.70%。期刊涵盖肿瘤学全领域研究,包括分子机制、临床诊疗、影像技术等,被PubMed、SCIE等20余个国际数据库收录。

  一、期刊亮点

  1.高发文量:年发文量超4000篇,录用概率显著高于同类期刊;

  2. 审稿效率卓越:平均14周完成录用,支持“快速审稿通道”缩短至8周;

  3. 跨学科兼容性:接收临床病例报告、生物信息学分析、影像组学研究等多元类型;

  4. 性价比突出:相较于同分区期刊,APC费用处于行业中等水平。

  二、征稿方向

  包含并不限于:

  • 肿瘤免疫治疗与靶向药物研发;

  • 癌症代谢重编程机制;

  • 放射治疗与影像引导技术;

  • 人工智能辅助癌症诊断;

  • 肿瘤微环境与转移调控;

  • 儿科肿瘤精准治疗;

  • 心血管毒性等治疗副作用管理;

  • 多组学与生物标志物挖掘

  三、作者指南

  Writing and formatting

  Title

  The title should be concise, omitting terms that are implicit and, where possible, be a statement of the main result or conclusion presented in the manuscript. Abbreviations should be avoided within the title.

  Witty and creative titles are welcome, but only if relevant and within measure. Consider if a title meant to be thought-provoking might be misinterpreted as offensive or alarming. In extreme cases, the editorial office may veto a title and propose an alternative.

  Authors should avoid:

  titles that are a mere question without giving the answer

  unambitious titles, for example starting with 'Towards,' 'A description of,' 'A characterization of' or 'Preliminary study on'

  vague titles, for example starting with 'Role of', 'Link between', or 'Effect of' that do not specify the role, link, or effect

  including terms that are out of place, for example the taxonomic affiliation apart from species name.

  Abstract

  As a primary goal, the abstract should make the general significance and conceptual advance of the work clearly accessible to a broad readership. The abstract should be no longer than a single paragraph and should be structured, for example, according to the IMRAD format. For the specific structure of the abstract, authors should follow the requirements of the article type or journal to which they're submitting. Minimize the use of abbreviations and do not cite references, figures or tables.

  For clinical trial articles, please include the unique identifier and the URL of the publicly accessible website on which the trial is registered.

  Manuscript length

  We encourage you to closely follow the article word count lengths given in the 'Article types' page of the journals. The manuscript length includes only the main body of the text, footnotes, and all citations within it, and excludes the abstract, section titles, figure and table captions, funding statement, acknowledgments, and references in the bibliography. Please indicate the number of words and the number of figures and tables included in your manuscript on the first page.

  Sections

  The manuscript is organized by headings and subheadings. The section headings should be those appropriate for your field and the research itself. You may insert up to 5 heading levels into your manuscript (i.e.,: 3.2.2.1.2 Heading Title).

  For Original Research articles, it is recommended to organize your manuscript in the following sections or their equivalents for your field.

  Introduction

  Succinct, with no subheadings.

  Materials and methods

  This section may be divided by subheadings and should contain sufficient detail so that when read in conjunction with cited references, all procedures can be repeated. For experiments reporting results on animal or human subject research, an ethics approval statement should be included in this section (for further information, see the 'Bioethics' section of our policies and publication ethics.)

  Results

  This section may be divided by subheadings. Footnotes should not be used and must be transferred to the main text.

  Discussion

  This section may be divided by subheadings. Discussions should cover the key findings of the study: discuss any prior research related to the subject to place the novelty of the discovery in the appropriate context, discuss the potential shortcomings and limitations on their interpretations, discuss their integration into the current understanding of the problem and how this advances the current views, speculate on the future direction of the research, and freely postulate theories that could be tested in the future.

  For further information, please check the descriptions defined in the journal's 'Article types' page, in the 'For authors' menu on every journal page.

  四、出版费用

  五、文章类型

  投稿前建议通过咨询在线学术顾问进行稿件预审,快速了解预审结果提高投稿准确度,节省投稿时间。如果你还想了解更多肿瘤学SCI期刊方向的知识,可点击在线学术顾问,免费咨询。

热门服务 全程指导,100%成功保障,最大限度节省科研人员时间,限时秒杀中……

📝

SCI/SSCI/EI全程指导

专业选刊推荐与投稿全程指导

🔍

南核/北核全程指导

根据研究方向推荐合适期刊

✍️

知网/万方/维普/龙源指导

专业学术文章翻译与校对

翻译/润色服务

英美母语专家润色提升论文质量,专业学术文章翻译与校对

📊

本硕毕业大论文指导

一对一导师全程指导

📚

学术著作出版

专业学术著作出版服务

📄

中国专服务利

中国发明专利、实用新型专利

🔬

国际专利服务

科研数据分析与可视化

专业服务顾问

吕老师

期刊投稿顾问

工作认真负责、积极主动、注重协作,善于团队工作,适应能力强。

立即咨询

崔老师

期刊投稿顾问

对生活充满希望,对工作充满热情!

立即咨询

李老师

期刊投稿顾问

工作认真负责、积极主动、注重协作,善于团队工作,适应能力强。

立即咨询

孙老师

期刊投稿顾问

性格沉稳、细致、观察力强、上进心极强,为人随和,易于沟通,能够比较轻易地融入工作,发挥所长。

立即咨询

姚老师

期刊投稿顾问

本人善良、自信、自律、上进心强,有较强的组织、管理能力。工作认真负责,勇于承担任务与责任。

立即咨询

徐老师

期刊投稿顾问

性格开朗、乐于助人,做事严谨仔细、认真负责。同时善于观察周围的事物,善于收集资料分析问题。

立即咨询

集群智慧云科服平台

集群智慧云科服平台是一个综合性的科研服务平台,致力于为科研工作者提供全方位的学术支持服务。平台整合了期刊投稿、论文润色、学术翻译、科研数据分析等多种功能,帮助研究人员更高效地开展科研工作并提升研究成果的影响力。我们的专业团队由各学科领域的专家组成,确保为每一位用户提供个性化、专业化的服务。

集群智慧云科服 集群智慧云企服 集群智慧职称云 考研重点网